Angela Lupattelli

• Lupattelli, Angela; Wood, Mollie; Ystrøm, Eivind; Skurtveit, Svetlana; Handal, Marte & Nordeng, Hedvig Marie Egeland (2018). Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.  Journal of the American Academy of Child and Adolescent Psychiatry.  ISSN 0890-8567.  57(3), s 200- 208 . doi:10.1016/j.jaac.2017.12.010 Full text in Research Archive.
• Lupattelli, Angela; Twigg, Michael J; Zagorodnikova, Ksenia; Moretti, Myla Emily; Drozd, Mariola; Panchaud, Alice; Rieutord, Andre; Juraski, Romana Gjergia; Odalovic, Marina; Kennedy, Debra; Rudolf, Gorazd; Juch, Herbert & Nordeng, Hedvig Marie Egeland (2018). Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.  Clinical Epidemiology.  ISSN 1179-1349.  10, s 655- 669 . doi:10.2147/CLEP.S156210 Full text in Research Archive.
• Lupattelli, Angela; Wood, Mollie; Lapane, Kate L; Spigset, Olav & Nordeng, Hedvig Marie Egeland (2017). Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.  Pharmacoepidemiology and Drug Safety.  ISSN 1053-8569.  26(10), s 1266- 1276 . doi:10.1002/pds.4286 Full text in Research Archive.
• Lupattelli, Angela; Spigset, Olav; Björnsdottir, Ingunn; Hämeen-Anttila, Katri; Mårdby, Ann-Charlotte; Panchaud, Alice; Juraski, Romana Gjergia; Rudolf, Gorazd; Odalovic, Marina; Drozd, Mariola; Twigg, Michael J.; Juch, Herbert; Moretti, Myla Emily; Kennedy, Debra; Rieutord, Andre; Zagorodnikova, Ksenia; Passier, Anneke & Nordeng, Hedvig Marie Egeland (2015). Patterns and factors associated with low adherence to psychotropic medications during pregnancy - a cross-sectional, multinational web-based study. Depression and Anxiety.  ISSN 1091-4269.  32(6), s 426- 436 . doi: 10.1002/da.22352

• Lupattelli, Angela; Branquinho, Mariana; Cardoso, Catarina; Tauqeer, Fatima; Bjørndal, Ludvig Daae & Fonseca, Ana (2024). Psychometric properties of the Decisional Conflict Scale in a sample of perinatal women with depressive symptoms: A study in Portugal and Norway. Patient Education and Counseling. ISSN 0738-3991. 127. doi: 10.1016/j.pec.2024.108337.
• Mitter, Vera; Lupattelli, Angela; Bjørk, Marte-Helene & Nordeng, Hedvig Marie Egeland (2024). Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study. Cephalalgia. ISSN 0333-1024. 44(4). doi: 10.1177/03331024241248846.
• Orangzeb, Saima; Desalegn, Anteneh Assefa; Trinh, Nhung; Zhao, Jing; Nordeng, Hedvig Marie Egeland & Lupattelli, Angela (2024). COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals. Vaccine. ISSN 0264-410X. doi: 10.1016/j.vaccine.2024.04.039.
• Moreno-Martos, David; Zhao, Jing; Li, Huiqi; Nyberg, Fredrik; Bjørndal, Ludvig Daae & Hajiebrahimi, Mohammadhossein [Vis alle 13 forfattere av denne artikkelen] (2024). Impact of the early COVID-19 pandemic on adult mental health-related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysis. British Journal of Clinical Pharmacology. ISSN 0306-5251. doi: 10.1111/bcp.16044.
• Esposito, Giovanna; Cantarutti, Anna; Lupattelli, Angela; Franchi, Matteo; Corrao, Giovanni & Parazzini, Fabio (2024). Does preterm birth increase the initiation of antidepressant use during the postpartum? A population-based investigation. Frontiers in Pharmacology. ISSN 1663-9812. 15. doi: 10.3389/fphar.2024.1325381.
• Liu, Xiaoqin; Trinh, Nhung TH; Wray, Naomi R.; Lupattelli, Angela; Albiñana, Clara & Agerbo, Esben [Vis alle 9 forfattere av denne artikkelen] (2024). Impact of genetic, sociodemographic, and clinical features on antidepressant treatment trajectories in the perinatal period. European Neuropsychopharmacology. ISSN 0924-977X. 81, s. 20–27. doi: 10.1016/j.euroneuro.2024.01.010.
• Hurley, Eimir; Geisler, Benjamin Peter; Lupattelli, Angela; Poblador-Plou, Beatriz; Lassalle, Régis & Jové, Jérémy [Vis alle 30 forfattere av denne artikkelen] (2024). COVID-19 and pregnancy: A European study on pre- and post-infection medication use. European Journal of Clinical Pharmacology. ISSN 0031-6970. doi: 10.1007/s00228-024-03639-z.
• Nasrin, Tania; Tauqeer, Fatima; Bjørndal, Ludvig Daae; Kittel-Schneider, Sarah & Lupattelli, Angela (2024). Partner support for women’s antidepressant treatment and its association with depressive symptoms in pregnant women, mothers, and women planning pregnancy. Archives of Women's Mental Health. ISSN 1434-1816. doi: 10.1007/s00737-024-01435-3.
• Pedersen, Elisabeth; Tripodi, Elena; Aakjær, Mia; Li, Huiqi; Cantarutti, Anna & Nyberg, Fredrik [Vis alle 9 forfattere av denne artikkelen] (2024). Drug utilisation in children and adolescents before and after the start of the COVID-19 pandemic: Interrupted time-series analyses in three European countries. Paediatric and Perinatal Epidemiology. ISSN 0269-5022. doi: 10.1111/ppe.13046.
• Shakibfar, Saeed; Zhao, Jing; Li, Huiqi; Nordeng, Hedvig Marie Egeland; Lupattelli, Angela & Pavlović, Milena [Vis alle 12 forfattere av denne artikkelen] (2023). Machine learning-driven development of a disease risk score for COVID-19 hospitalization and mortality: a Swedish and Norwegian register-based study. Frontiers in Public Health. ISSN 2296-2565. 11. doi: 10.3389/fpubh.2023.1258840. Fulltekst i vitenarkiv
• Schreuder, Anton; Mokadem, Ibtissam; Smeets, Nori J. L; Spaanderman, Marc E. A; Roeleveld, Nel & Lupattelli, Angela [Vis alle 7 forfattere av denne artikkelen] (2023). Associations of periconceptional oral contraceptive use with pregnancy complications and adverse birth outcomes. International Journal of Epidemiology. ISSN 0300-5771. 52(5), s. 1388–1399. doi: 10.1093/ije/dyad045. Fulltekst i vitenarkiv
• Di Chiara, Costanza; Barbieri, Elisa; Chen, Yu Xi; Visonà, Elisa; Cavagnis, Sara & Sturniolo, Giulia [Vis alle 15 forfattere av denne artikkelen] (2023). Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19. Acta Paediatrica. ISSN 0803-5253. 112(12). doi: 10.1111/apa.16966. Fulltekst i vitenarkiv
• Tauqeer, Fatima; Moen, Anne; Myhr, Kirsten; Wilson, Claire A. & Lupattelli, Angela (2023). Assessing decisional conflict and challenges in decision-making among perinatal women using or considering using antidepressants during pregnancy—a mixed-methods study. Archives of Women's Mental Health. ISSN 1434-1816. 26, s. 669–683. doi: 10.1007/s00737-023-01341-0. Fulltekst i vitenarkiv Vis sammendrag

  This study aims to investigate decisional conflict and elucidate challenges in decision-making among perinatal women using or considering using antidepressant (AD) during pregnancy. A sequential, mixed-methods study was employed among pregnant and postnatal women in Norway who had been offered ADs in the last 5 years. Quantitative data were obtained through an electronic questionnaire. Decisional conflict in pregnancy was assessed using the Decisional Conflict Scale (DCS) defined as either low (

• Lupattelli, Angela; Corrao, Giovanni; Gatti, Chiara; Rea, Federico; Trinh, Nhung & Cantarutti, Anna (2023). Antidepressant continuation and adherence in pregnancy, and risk of antenatal hospitalization for unipolar major depressive and/or anxiety disorders. Journal of Affective Disorders. ISSN 0165-0327. 339, s. 502–510. doi: 10.1016/j.jad.2023.07.066. Fulltekst i vitenarkiv
• Trinh, Nhung; Semark, Birgitte Dige; Munk-Olsen, Trine; Liu, Xiaoqin; Thapa, Suraj Bahadur & Yilmaz, Zeynep [Vis alle 8 forfattere av denne artikkelen] (2023). Antidepressant treatment in pregnancy: a Danish registry linkage study in pregnant women with pre-existing obsessive‐compulsive disorder. Translational Psychiatry. ISSN 2158-3188. 13(1). doi: 10.1038/s41398-023-02516-0. Fulltekst i vitenarkiv
• Lupattelli, Angela; Trinh, Nhung & Nordeng, Hedvig Marie Egeland (2023). Association of maternal personality traits with medication use during pregnancy to appraise unmeasured confounding in long-term pharmacoepidemiological safety studies. Frontiers in Pharmacology. ISSN 1663-9812. 14. doi: 10.3389/fphar.2023.1160168. Fulltekst i vitenarkiv
• Trinh, Nhung; Munk-Olsen, Trine; Wray, Naomi R.; Bergink, Veerle; Nordeng, Hedvig Marie Egeland & Lupattelli, Angela [Vis alle 7 forfattere av denne artikkelen] (2023). Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway. JAMA psychiatry. ISSN 2168-6238. 80(5), s. 441–450. doi: 10.1001/jamapsychiatry.2023.0041.
• Fonseca, Ana; Branquinho, Mariana; Monteiro, Fabiana; Araújo-Pedrosa, Anabela; Bjørndal, Ludvig Daae & Lupattelli, Angela (2023). Treatment options and their uptake among women with symptoms of perinatal depression: exploratory study in Norway and Portugal. BJPsych Open. ISSN 2056-4724. 9(3), s. 1–9. doi: 10.1192/bjo.2023.56. Fulltekst i vitenarkiv
• Tauqeer, Fatima; Ceulemans, Michael; Gerbier, Eva; Passier, Anneke; Oliver, Alison & Foulon, Veerle [Vis alle 9 forfattere av denne artikkelen] (2023). Mental health of pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European cross-sectional study. BMJ Open. ISSN 2044-6055. 13(1). doi: 10.1136/bmjopen-2022-063391. Fulltekst i vitenarkiv Vis sammendrag

  Objective: To describe the mental health of perinatal women in five European countries during the third pandemic wave and identify risk factors related to depressive and anxiety symptoms. Design: A cross-sectional, online survey-based study. Setting: Belgium, Norway, Switzerland, the Netherlands and the UK, 10 June 2021-22 August 2021. Participants: Pregnant and up to 3 months postpartum women, older than 18 years of age. Primary outcome measure: The Edinburgh Depression Scale (EDS) and the Generalised Anxiety Disorder scale (GAD-7) were used to assess mental health status. Univariate and multivariate generalised linear models were performed to identify factors associated with poor mental health. Results: 5210 women participated (including 3411 pregnant and 1799 postpartum women). The prevalence of major depressive symptoms (EDS ≥13) was 16.1% in the pregnancy group and 17.0% in the postpartum . Moderate to severe generalised anxiety symptoms (GAD ≥10) were found among 17.3% of the pregnant and 17.7% of the postpartum women. Risk factors associated with poor mental health included having a pre-existing mental illness, a chronic somatic illness, having had COVID-19 or its symptoms, smoking, unplanned pregnancy and country of residence. Among COVID-19 restrictive measures specific to perinatal care, pregnant and postpartum women were most anxious about not having their partner present at the time of delivery, that their partner had to leave the hospital early and to be separated from their newborn after the delivery. Conclusion: Approximately one in six pregnant or postpartum women reported major depression or anxiety symptoms during the third wave of the pandemic. These findings suggest a continued need to monitor depression and anxiety in pregnancy and postpartum populations throughout and in the wake of the pandemic. Tailored support and counseling are essential to reduce the burden of the pandemic on perinatal and infant mental health.

• Araya, Robin Aasegg; Tauqeer, Fatima; Ceulemans, Michael; Gerbier, Eva; Maisonneuve, Emeline & Passier, Anneke [Vis alle 10 forfattere av denne artikkelen] (2023). Pregnancy- and Birth-Related Experiences among Postpartum Women during the Third Wave of the COVID-19 Pandemic—A Multinational European Study. Pharmacoepidemiology. ISSN 2813-0618. 2(1), s. 54–67. doi: 10.3390/pharma2010006. Fulltekst i vitenarkiv Vis sammendrag

  The objective of this study was to describe pregnancy- and birth-related experiences of postpartum women during the third wave of the COVID-19 pandemic and their association with mental health outcomes. An online questionnaire was distributed in five European countries (Belgium, The Netherlands, Norway, Switzerland, UK) between June and August 2021. Participants were recruited though socialmedia platforms including pregnancy- and motherhood-related websites, pregnancy fora, and apps. Postpartum women were asked eleven specific questions about pregnancyand birth-related changes and the presence of support during delivery. The Edinburgh Depression Scale was used to assess depressive and anxiety symptoms. Covariates included sociodemographics, health and reproductive characteristics, and COVID-19 status. Associations were estimated with logistic regression. The study included 1730 postpartum women. Frequent changes included the exclusion of the partner from pregnancy care appointments (83.2%), changed prenatal care settings (64.4%), and cancellation of hospital information visits (42.7%). Few women, however, were without support apart from medical staff during delivery (1.4%). The number of pregnancy- and birth-related changes was associated with each woman’s mental health status, as well as the type of change. Experiencing changes related to delivery and cancellation or reduction of prenatal examination was associated with a doubling in the odds of symptoms of major depression and anxiety postpartum. These findings highlight the importance of ensuring adequate maternity care for women’s mental health postpartum, as well as during a pandemic.

• Trinh, Nhung; Nordeng, Hedvig Marie Egeland; Bandoli, Gretchen; Palmsten, Kristin; Eberhard-Gran, Malin & Lupattelli, Angela (2022). Antidepressant Fill and Dose Trajectories in Pregnant Women with Depression and/or Anxiety: A Norwegian Registry Linkage Study. Clinical Epidemiology. ISSN 1179-1349. 14, s. 1439–1451. doi: 10.2147/CLEP.S379370. Fulltekst i vitenarkiv
• Trinh, Nhung; Semark, Birgitte Dige; Munk-Olsen, Trine; Liu, Xiaoqin; Rø, Øyvind & Bulik, Cynthia M. [Vis alle 9 forfattere av denne artikkelen] (2022). Psychiatric visits during the postpartum year in women with eating disorders who continue or discontinue antidepressant treatment in pregnancy. International Journal of Eating Disorders. ISSN 0276-3478. 56(3), s. 582–594. doi: 10.1002/eat.23877. Fulltekst i vitenarkiv
• Motrico, Emma; Moreno-Peral, Patricia; Uriko, Kristiina; Hancheva, Camellia; Brekalo, Maja & Ajaz, Erilda [Vis alle 19 forfattere av denne artikkelen] (2022). Clinical practice guidelines with recommendations for peripartum depression: A European systematic review. Acta Psychiatrica Scandinavica. ISSN 0001-690X. 146(4), s. 325–339. doi: 10.1111/acps.13478. Fulltekst i vitenarkiv
• Deeb, George; Diaz Perez, Esperanza; Haavik, Svein & Lupattelli, Angela (2022). Medication Use among Immigrants from Syria Living in Western Norway: A Cross-Sectional Study. Pharmacoepidemiology. ISSN 2813-0618. 1(2), s. 76–88. doi: 10.3390/pharma1020008. Fulltekst i vitenarkiv
• Bjørndal, Ludvig Daae; Tauqeer, Fatima; Heiervang, Kristin Sverdvik; Clausen, Hanne Kristin; Heitmann, Kristine & Lupattelli, Angela (2022). Perceived risk of neurodevelopmental outcomes in offspring related to psychotropic and mental illness exposures in pregnancy and breastfeeding: a cross-sectional survey of women with past or current mental illness. BMJ Open. ISSN 2044-6055. 12(9), s. 1–11. doi: 10.1136/bmjopen-2022-061159. Fulltekst i vitenarkiv Vis sammendrag

  Objectives: To investigate the perceived risk of psychotropic and mental illness exposures (1) during pregnancy or (2) while breastfeeding on offspring neurodevelopment, and factors associated with this perception in women with past/current mental illness. Design: Cross-sectional, web-based study. Setting: Nationwide in Norway, June 2020-June 2021. Participants: Women aged 18-55 years who were pregnant, recent mothers or planning a pregnancy, and had been offered antidepressants in the last 5 years. Primary and secondary outcome measures: Perceived risk of prenatal and breastmilk exposure to psychotropic medications and maternal mental illness on offspring neurodevelopmental outcomes. Results: We included 448 women: 234 pregnant, 146 mothers and 68 planning a pregnancy. On a 0-10 scale, women perceived antidepressants as least harmful both (1) in pregnancy (mean score 4.2, 95% CI 3.6 to 4.8) and (2) while breastfeeding (mean score 3.8, 95% CI 3.3 to 4.4), relative to antipsychotics, anxiety/sleeping medication or antiepileptics (mean score range: 6.3-6.5 during pregnancy, 5.5-6.2 while breastfeeding). Many participants were unfamiliar with psychotropics other than antidepressants. The perceived risk of mental illness exposure exceeded that of antidepressants (mean score range 5.6-5.9) in both exposure periods. Using general linear models, factors associated with greater antidepressant risk perception in both exposure periods included having lower education, non-Norwegian native language, and employment status (range mean score difference (β): 2.07-6.07). For pregnant women and mothers, there was an inverse association between perceived risk and the perceived antidepressant effectiveness in both exposure periods (range of β: -0.18 to -0.25). Conclusions: In women with past/current mental illness, the perceived risk of antidepressant exposure on child neurodevelopment was lower than that for maternal mental illness. Other psychotropic medications were perceived as more harmful. As medication risk perception influences the decision-making regarding treatment of mental illness, pre- and pregnancy counselling should target women with characteristics associated with higher perceived risk. Keywords: EPIDEMIOLOGY; MENTAL HEALTH; OBSTETRICS; PSYCHIATRY; THERAPEUTICS. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

• Trinh, Nhung; Nordeng, Hedvig Marie Egeland; Bandoli, Gretchen; Eberhard-Gran, Malin Marie Cecilia & Lupattelli, Angela (2022). Antidepressant and mental health care utilization in pregnant women with depression and/or anxiety: An interrupted time-series analysis. Journal of Affective Disorders. ISSN 0165-0327. 308, s. 458–465. doi: 10.1016/j.jad.2022.04.101. Fulltekst i vitenarkiv
• Trønnes, Johanne Naper; Lupattelli, Angela; Ystrøm, Eivind & Nordeng, Hedvig Marie Egeland (2022). Analysis of Prenatal Exposure to Opioid Analgesics and Scholastic Skills in Children in Fifth Grade in Norway. JAMA Network Open. ISSN 2574-3805. 5(7). doi: 10.1001/jamanetworkopen.2022.22425. Fulltekst i vitenarkiv
• Liu, Xiaoqin; Molenaar, Nina; Agerbo, Esben; Momen, Natalie C.; Rommel, Anna-Sophie & Lupattelli, Angela [Vis alle 8 forfattere av denne artikkelen] (2022). Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: A population-based propensity score-matched cohort study. PLoS Medicine. ISSN 1549-1277. 19(1). doi: 10.1371/journal.pmed.1003895. Fulltekst i vitenarkiv
• Kittel-Schneider, Sarah; Felice, Ethel; Buhagiar, Rachel; Lambregtse-Van Den Berg, Mijke; Wilson, Claire A. & Baljak, Visnja Banjac [Vis alle 11 forfattere av denne artikkelen] (2022). Treatment of Peripartum Depression with Antidepressants and Other Psychotropic Medications: A Synthesis of Clinical Practice Guidelines in Europe. International Journal of Environmental Research and Public Health (IJERPH). ISSN 1661-7827. 19(4). doi: 10.3390/ijerph19041973. Fulltekst i vitenarkiv
• Barbieri, Elisa; Liberati, Cecilia; Cantarutti, Anna; Di Chiara, Costanza; Lupattelli, Angela & Sharland, Michael [Vis alle 9 forfattere av denne artikkelen] (2022). Antibiotic Prescription Patterns in the Paediatric Primary Care Setting before and after the COVID-19 Pandemic in Italy: An Analysis Using the AWaRe Metrics. Antibiotics. ISSN 2079-6382. 11(4). doi: 10.3390/antibiotics11040457. Fulltekst i vitenarkiv
• Lupattelli, Angela; Barone-Adesi, Francesco & Nordeng, Hedvig Marie Egeland (2021). Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. 31(2), s. 247–256. doi: 10.1002/pds.5388. Fulltekst i vitenarkiv
• Ngo, Elin Thuy Phuong; Spigset, Olav; Lupattelli, Angela; Panchaud, Alice; Annaert, Pieter & Allegaert, Karel [Vis alle 7 forfattere av denne artikkelen] (2021). Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review. Basic & Clinical Pharmacology & Toxicology. ISSN 1742-7835. doi: 10.1111/bcpt.13663. Fulltekst i vitenarkiv Vis sammendrag

  Current data on use of antihistamines during breastfeeding and risks to the breastfed infant are insufficient. The aim of this systematic review was to provide an overview of studies measuring the levels of antihistamines in human breast milk, estimating the exposure for breastfed infants and/or reporting possible adverse effects on the breastfed infant. An additional aim was to review the antihistamine product labels available in the European Union (EU) and the United States. We searched seven online databases and identified seven human lactation studies that included 25 mother–infant pairs covering cetirizine, clemastine, ebastine, epinastine, loratadine, terfenadine and triprolidine. In addition, one study investigated the impact of chlorpheniramine or promethazine on prolactin levels among 17 women, and one study investigated possible adverse drug reactions in 85 breastfed infants exposed to various antihistamines. The relative infant dose was below 5% for all antihistamines, ranging from 0.3% for terfenadine to 4.5% for clemastine. Most product labels of the 10 antihistamines with available information in both the EU and the United States reported lack of evidence and recommended to avoid use during breastfeeding. The knowledge gap on antihistamines and lactation is extensive, and further human studies are warranted to ensure optimal treatment of breastfeeding women with allergy.

• Wood, Mollie; Lupattelli, Angela; Palmsten, Kristin; Bandoli, Gretchen; Hurault-Delarue, Caroline & Damase-Michel, Christine [Vis alle 9 forfattere av denne artikkelen] (2021). Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy. Epidemiologic Reviews. ISSN 0193-936X. 43(1), s. 130–146. doi: 10.1093/epirev/mxab002. Fulltekst i vitenarkiv
• Lupattelli, Angela; Mahic, Milada; Handal, Marte; Ystrøm, Eivind; Reichborn-Kjennerud, Ted & Nordeng, Hedvig Marie Egeland (2021). Attention-Deficit/Hyperactivity Disorder in Children Following Prenatal Exposure to Antidepressants: results from the Norwegian Mother, Father and Child Cohort Study. BJOG: An International Journal of Obstetrics and Gynaecology. ISSN 1470-0328. 128(21), s. 1917–1927. doi: 10.1111/1471-0528.16743. Fulltekst i vitenarkiv
• Trønnes, Johanne Naper; Lupattelli, Angela; Handal, Marte; Skurtveit, Svetlana Ondrasova; Ystrom, Eivind & Nordeng, Hedvig Marie Egeland (2021). Association of Timing and Duration of Prenatal Analgesic Opioid Exposure with Attention-Deficit/Hyperactivity Disorder in Children. JAMA Network Open. ISSN 2574-3805. 4(9), s. 1–14. doi: 10.1001/jamanetworkopen.2021.24324. Fulltekst i vitenarkiv
• Andersen, Sarah Hjorth; Lupattelli, Angela; Handal, Marte; Spigset, Olav; Ystrøm, Eivind & Nordeng, Hedvig Marie Egeland (2021). Prenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder - a Follow-Up Study in the Norwegian Mother, Father and Child Cohort. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. 30(10), s. 1380–1390. doi: 10.1002/pds.5250. Fulltekst i vitenarkiv
• Gustavson, Kristin; Ystrøm, Eivind; Ask, Helga; Torvik, Fartein Ask; Hornig, Mady & Susser, Ezra [Vis alle 16 forfattere av denne artikkelen] (2021). Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder - a longitudinal sibling control study. JCPP Advances. ISSN 2692-9384. 1(2). doi: 10.1002/jcv2.12020. Fulltekst i vitenarkiv
• Tauqeer, Fatima; Wood, Mollie; Andersen, Sarah Hjorth; Lupattelli, Angela & Nordeng, Hedvig (2021). Perinatal use of triptans and other drugs for migraine - A nationwide drug utilization study. PLOS ONE. ISSN 1932-6203. 16(8). doi: 10.1371/journal.pone.0256214. Fulltekst i vitenarkiv Vis sammendrag

  Objective To characterize nationwide utilization patterns of migraine pharmacotherapy before, during, and after pregnancy in women with triptan use. Methods Population-based data were obtained by linking the Medical Birth Registry of Norway and the Norwegian Prescription Database from 2006 to 2017. We included 22,940 pregnancies among 19,669 women with at least one filled triptan prescription, a proxy for migraine, in the year before pregnancy or during pregnancy. The population was classified into four groups: i) continuers; ii) discontinuers; iii) initiators, and vi) post-partum re-initiators. Participant characteristics and prescription fills for other drugs such as analgesics, antinauseants, and preventive drugs among the groups were examined, along with an array of triptan utilization parameters. Results In total, 20.0% of the women were classified as triptan continuers, 54.1% as discontinuers, 8.0% as initiators, and 17.6% as re-initiators. Extended use of triptans (�15 daily drug doses/month) occurred among 6.9% of the continuers in the first trimester. The top 10% of triptan continuers and initiators accounted for 41% (95% CI: 39.2% - 42.5%) and 33% (95% CI: 30.3% - 35.8%) of the triptan volume, respectively. Triptan continuers and initiators had similar patterns of acute co-medication during pregnancy, but use of preventive drugs was more common among the continuers before, during, and after pregnancy. Conclusion Among women using triptans before and during pregnancy, one in four continued triptan treatment during pregnancy, and extended triptan use was relatively low. Triptan discontinuation during and in the year after pregnancy was common. Use of other acute migraine treatments was higher among both continuers and initiators of triptans. Women using preventive migraine treatment were most commonly triptan continuers and re-initiators after pregnancy. Prescribing to and counseling of women with migraine should be tailored to the condition severity and their information needs to promote optimal migraine management in pregnancy. Introduction

• Khalil, Nebghouha El; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2021). Antithyroid drug treatment and pregnancy outcomes among women with hyperthyroidism in pregnancy: A Norwegian population-based registry-linkage study. Norsk Epidemiologi. ISSN 0803-2491. 29(1-2), s. 71–84. doi: 10.5324/nje.v29i1-2.4048. Fulltekst i vitenarkiv Vis sammendrag

  Aims:The aim of this study was two-fold: i) to describe factors associated with antithyroid drug (ATD) treat-ment during gestation among women with hyperthyroidism in pregnancy,ii) to investigate the impact of ATD treatment during gestation on pregnancy outcomes.Methods:Women with hyperthyroidism in pregnancy and ATD treatments were identified through linkage of three national registries (2008-2018): The Medical Birth Registry of Norway, the Norwegian Prescription Registry and the Norwegian Patient Registry. Pregnancies were categorized as ATD treated or untreated based on filled prescriptions indicating ATD exposure during pregnancy. ATD treatment was examined by trimester (T1, T2/T3) and by substance carbimazole (CMZ), propylthiouracil (PTU) and by both CMZ/PTU. Generalized estimatingequations analysis with a robust variance estimator wasused to estimate adjusted odds ratio(aOR)and adjusted standardized mean difference(aSMD)with 95% confidence interval (CI).Results:We identified 1699 pregnancies with hyperthyroidism during gestation. Hyperthyroidism was treated with ATD in 44.4% of the pregnancies, while 55.6% were untreated. Pregnant women treated with ATD had more often asthma compared to untreated women. Prenatalexposure to CMZ was associated with increased risk of preterm birth (aOR 1.8, 95% CI 1.1-2.8) whereas PTU exposure in the first trimester was associated with an increased risk of cardiac malformations (aOR 9.0, 95% CI 1.8-44.7). There was no association between ATD treatment in pregnancy and maternal preeclampsia (aOR 0.8, 95% CI 0.4-1.3) and gestational hypertension (aOR 0.9, 95% CI 0.5-1.8).Conclusion:This nationwide registry study found an association between treatment with carbimazole and in-creased risk of preterm birth. Exposure to propylthiouracil in the first trimester was associated with an increased risk of cardiac malformations. These findings should be interpreted in light of international findings on the risk of untreated hyperthyroidism and the potential risk of ATD treatment for the mother and child.

• Ilic, Miljana; Nordeng, Hedvig Marie Egeland & Lupattelli, Angela (2021). Medical care contact for infertility and related medication use during pregnancy – a European, cross-sectional web-based study. Norsk Epidemiologi. ISSN 0803-2491. 29(1-2), s. 97–106. doi: 10.5324/nje.v29i1-2.4051. Fulltekst i vitenarkiv
• Vallee, Jennifer; Wong, Yih; Mannino, Eline; Nordeng, Hedvig Marie Egeland & Lupattelli, Angela (2020). Association between Antidepressant Treatment during Pregnancy and Postpartum Self-Harm Ideation in Women with Psychiatric Disorders: A Cross-Sectional, Multinational Study. International Journal of Environmental Research and Public Health (IJERPH). ISSN 1661-7827. 18(1), s. 1–15. doi: 10.3390/ijerph18010046. Fulltekst i vitenarkiv
• Lupattelli, Angela; Picinardi, Marta; Cantarutti, Anna & Nordeng, Hedvig Marie Egeland (2020). Use and intentional avoidance of prescribed medications in pregnancy: A cross-sectional, web-based study among 926 women in Italy. International Journal of Environmental Research and Public Health (IJERPH). ISSN 1661-7827. 17(11). doi: 10.3390/ijerph17113830. Fulltekst i vitenarkiv
• Lupattelli, Angela; Barone-Adesi, Francesco & Nordeng, Hedvig Marie Egeland (2020). Prenatal antidepressant use and maternal weight gain in pregnancy: results from the Norwegian Mother and Child Cohort Study. Reproductive Toxicology. ISSN 0890-6238. 97. doi: 10.1016/j.reprotox.2020.04.032.
• Lupattelli, Angela; Barone-Adesi, Francesco & Nordeng, Hedvig Marie Egeland (2020). Risk of gestational diabetes mellitus after use of antidepressant medication in pregnancy: results from the Norwegian Mother and Child Cohort Study. Reproductive Toxicology. ISSN 0890-6238. 97. doi: 10.1016/j.reprotox.2020.04.010.
• Broek, Sophie van den; Lupattelli, Angela; Frank, Anna-Simone; Haug, Line Småstuen & Nordeng, Hedvig Marie Egeland (2020). Thyroid hormone replacement therapy in pregnancy and motor function, communication skills, and behavior of preschool children: The Norwegian Mother, Father, and Child Cohort Study. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. s. 1–11. doi: 10.1002/pds.5184. Fulltekst i vitenarkiv
• Roldan Munoz, Sonia; Lupattelli, Angela; De Vries, Sieta T; Mol, Peter & Nordeng, Hedvig Marie Egeland (2020). Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: A cross-sectional, multinational, web-based study. BMJ Open. ISSN 2044-6055. 10(2), s. 1–11. doi: 10.1136/bmjopen-2019-034529. Fulltekst i vitenarkiv
• Fonseca, Ana; Ganho-Ávila, Ana; Lambregtse-van den Berg, Mijke; Lupattelli, Angela; Rodriguez-Muñoz, Maria de la Fé & Ferreira, Pedro [Vis alle 8 forfattere av denne artikkelen] (2020). Emerging issues and questions on peripartum depression prevention, diagnosis and treatment: a consensus report from the cost action riseup-PPD. Journal of Affective Disorders. ISSN 0165-0327. 274, s. 167–173. doi: 10.1016/j.jad.2020.05.112.
• Frank, Anna-Simone; Matteson, David S.; Solvang, Hiroko Kato; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2020). Extending balance assessment for the generalized propensity score under multiple imputation. Epidemiologic Methods. ISSN 2194-9263. 9(1). doi: 10.1515/em-2019-0003. Fulltekst i vitenarkiv Vis sammendrag

  This manuscript extends the definition of the Absolute Standardized Mean Difference (ASMD) for binary exposure (M = 2) to cases for M > 2 on multiple imputed data sets. The Maximal Maximized Standardized Difference (MMSD) and the Maximal Averaged Standardized Difference (MASD) were proposed. For different percentages, missing data were introduced in covariates in the simulated data based on the missing at random (MAR) assumption. We then investigate the performance of these two metric definitions using simulated data of full and imputed data sets. The performance of the MASD and the MMSD were validated by relating the balance metrics to estimation bias. The results show that there is an association between the balance metrics and bias. The proposed balance diagnostics seem therefore appropriate to assess balance for the generalized propensity score (GPS) under multiple imputation.

• Lupattelli, Angela; Wood, Mollie & Nordeng, Hedvig Marie Egeland (2019). Analyzing Missing Data in Perinatal Pharmacoepidemiology Research: Methodological Considerations to Limit the Risk of Bias. Clinical Therapeutics. ISSN 0149-2918. 41(12), s. 2477–2487. doi: 10.1016/j.clinthera.2019.11.003. Fulltekst i vitenarkiv
• Frank, Anna-Simone; Lupattelli, Angela; Brandlistuen, Ragnhild Eek & Nordeng, Hedvig Marie Egeland (2019). Maternal thyroid hormone replacement therapy exposure and language and communication skills of offspring at 8 years of age. JAMA Network Open. ISSN 2574-3805. 2(10), s. 1–15. doi: 10.1001/jamanetworkopen.2019.12424. Fulltekst i vitenarkiv
• Frank, Anna-Simone; Lupattelli, Angela; Matteson, David S.; Meltzer, Helle Margrete & Nordeng, Hedvig Marie Egeland (2019). Thyroid hormone replacement therapy patterns in pregnant women and perinatal outcomes in the offspring. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. 29(1), s. 111–121. doi: 10.1002/pds.4927. Fulltekst i vitenarkiv
• Trønnes, Johanne Naper; Wood, Mollie; Lupattelli, Angela; Ystrøm, Eivind & Nordeng, Hedvig Marie Egeland (2019). Prenatal paracetamol exposure and neurodevelopmental outcomes in preschool-aged children. Paediatric and Perinatal Epidemiology. ISSN 0269-5022. 34(3), s. 247–256. doi: 10.1111/ppe.12568. Fulltekst i vitenarkiv
• Ceulemans, Michael; Lupattelli, Angela; Nordeng, Hedvig Marie Egeland; Odalovic, Marina; Twigg, Michael J. & Foulon, Veerle (2019). Women’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists. Current pharmaceutical design. ISSN 1381-6128. 25(5), s. 469–482. doi: 10.2174/1381612825666190321110420. Fulltekst i vitenarkiv
• Hjorth, Sarah ; Bromley, Rebecca; Ystrom, Eivind; Lupattelli, Angela; Spigset, Olav & Nordeng, Hedvig Marie Egeland (2019). Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications – A systematic review. PLOS ONE. ISSN 1932-6203. 14(7), s. 1–37. doi: 10.1371/journal.pone.0219778. Fulltekst i vitenarkiv
• Svensberg, Karin; Nordeng, Hedvig Marie Egeland; Gaffari, Sahar; Faasse, Kate; Horne, Rob & Lupattelli, Angela (2019). Perceived sensitivity to medicines: a study among chronic medicine users in Norway. International Journal of Clinical Pharmacy. ISSN 2210-7703. 41(3), s. 804–812. doi: 10.1007/s11096-019-00826-2. Fulltekst i vitenarkiv
• Lupattelli, Angela; Chambers, Christina D.; Bandoli, Gretchen; Handal, Marte; Skurtveit, Svetlana & Nordeng, Hedvig Marie Egeland (2019). Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers. JAMA Network Open. ISSN 2574-3805. 2(4). doi: 10.1001/jamanetworkopen.2019.1435. Fulltekst i vitenarkiv
• Frank, Anna-Simone Josefine; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2018). Risk factors for discontinuation of thyroid hormone replacement therapy in early pregnancy: A study from the Norwegian Mother and Child Cohort Study and the Medical Birth Registry of Norway. American Journal of Obstetrics and Gynecology. ISSN 0002-9378. doi: 10.1111/aogs.13339.. Fulltekst i vitenarkiv
• Frank, Anna-Simone Josefine; Lupattelli, Angela; Matteson, David S. & Nordeng, Hedvig Marie Egeland (2018). Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns. Clinical Epidemiology. ISSN 1179-1349. 10, s. 1801–1816. doi: 10.2147/CLEP.S175616. Fulltekst i vitenarkiv
• Svensberg, Karin; Sporrong, Sofia K; Lupattelli, Angela; Olsson, Erika; Wallman, Andy & Björnsdottir, Ingunn (2018). Nordic pharmacy students? opinions of their patient communication skills training. American Journal of Pharmaceutical Education. ISSN 0002-9459. 82(2), s. 152–165. doi: 10.5688/ajpe6208.
• Lupattelli, Angela; Twigg, Michael J; Zagorodnikova, Ksenia; Moretti, Myla Emily; Drozd, Mariola & Panchaud, Alice [Vis alle 13 forfattere av denne artikkelen] (2018). Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale. Clinical Epidemiology. ISSN 1179-1349. 10, s. 655–669. doi: 10.2147/CLEP.S156210. Fulltekst i vitenarkiv
• Lupattelli, Angela; Rønningen, Elke; Krogsrud, Stine Kleppe; Nordeng, Hedvig Marie Egeland & Ystrøm, Eivind (2018). Personality and its relation to the use of alcohol and cigarettes during pregnancy: A multinational study. Journal of Health Psychology. ISSN 1359-1053. doi: 10.1177/1359105318775194. Fulltekst i vitenarkiv
• Lupattelli, Angela; Spigset, Olav & Nordeng, Hedvig Marie Egeland (2018). Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance. International Journal of Clinical Pharmacy. ISSN 2210-7703. 40(4), s. 783–786. doi: 10.1007/s11096-018-0672-2. Fulltekst i vitenarkiv
• Frank, Anna-Simone Josefine; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2018). Risk factors for discontinuation of thyroid hormone replacement therapy in early pregnancy: A study from the Norwegian Mother and Child Cohort Study and the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. 97(7), s. 852–860. doi: 10.1111/aogs.13339. Fulltekst i vitenarkiv

Se alle arbeider i Cristin

• Trinh, Nhung; Jödicke, Annika M; Català, Martí; Mercadé-Besora, Núria; Hayati, Saeed & Lupattelli, Angela [Vis alle 8 forfattere av denne artikkelen] (2024). Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. The Lancet Respiratory Medicine. ISSN 2213-2600. 12(5), s. e33–e34. doi: 10.1016/S2213-2600(24)00082-1.
• van Gelder, Marleen; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2023). Risk of spontaneous abortion after periconceptional medication use: Time to tackle the methodological challenges. Paediatric and Perinatal Epidemiology. ISSN 0269-5022. doi: 10.1111/ppe.12967. Fulltekst i vitenarkiv
• Nordeng, Hedvig Marie Egeland; Pedersen, Elisabeth; Hurley, Eimir; Zhao, Jing; Trinh, Nhung & Lupattelli, Angela (2022). EU-COVID-19 - a multinational registry-based study with focus on risk and protective factors, clinical outcomes and mental health.
• Pedersen, Elisabeth; Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2022). Primary care diagnoses in patients developing Post COVID-19 Condition.
• Lupattelli, Angela (2022). Ulike land har ulike retningslinjer for antidepressiva i svangerskapet. [Internett]. Titan.uio.no.
• Lupattelli, Angela (2022). Grei risikovurdering av psykofarmaka under svangerskap og amming. [Internett]. Titan.uio.no.
• Lupattelli, Angela (2022). Understanding the reproductive safety and effectiveness of antidepressant medications in pregnancy.
• Lupattelli, Angela (2022). VAC4EU active safety surveillance study of the BNT162B2 COVID-19 vaccine in five European countries: Study design and first results.
• Lupattelli, Angela (2022). Decisional conflict about antidepressant treatment in pregnant women with a mental illness in Norway.
• Lupattelli, Angela (2022). Prenatal Exposure to Antidepressants and Risk of Overweight and Obesity in Offspring at Age 8 Years. .
• Lupattelli, Angela (2022). Association between SARS-CoV-2 infection and its variants with placental weight and birthweight-to placental weight ratio - a planned national registry linkage study in Norway.
• Lupattelli, Angela (2022). Causal analysis of vaccination in pregnancy.
• Lupattelli, Angela (2022). Long-term safety of antidepressants in pregnancy on metabolic health outcomes in offspring.
• Lupattelli, Angela (2022). Association of Prenatal Antidepressant Exposure with Trajectories and Acceleration of Body Mass Index in Children from 6 Weeks to 8 Years of Age.
• Lupattelli, Angela (2022). Antidepressant Continuation and Adherence in Pregnancy and Risk of Antenatal Hospital Admission for Depression and/or Anxiety.
• Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2022). Does Intrapartum Epidural Analgesia Increase the Risk of Autism Spectrum Disorder in Offspring? Most Likely Not. JAMA Network Open. ISSN 2574-3805. doi: 10.1001/jamanetworkopen.2022.14279.
• Lupattelli, Angela & Trinh, Nhung (2022). Polysubstance Exposure During Pregnancy and Attention-Deficit/Hyperactivity Disorder in Offspring—Methodological Challenges and Opportunities for Future Research. JAMA Network Open. ISSN 2574-3805. 5(3). doi: 10.1001/jamanetworkopen.2022.1964. Fulltekst i vitenarkiv
• Lupattelli, Angela & Helleve, Torstein (2021). – Dersom du går på antidepressiva under svangerskapet, er det antakeleg best å fortsette. [Internett]. Forskning.no.
• Lupattelli, Angela & Helleve, Torstein (2021). Antidepressiva fjernar ikkje tankar om sjølvskading etter fødsel. [Internett]. Titan.uio.no.
• Lupattelli, Angela & Helleve, Torstein (2021). Forskarar sjekkar medisinar for ADHD-forbindelse. [Internett]. Titan.uio.no.
• Lupattelli, Angela & Borgan, Eldrid (2021). Kan antidepressiva gi barnet i magen autisme? En ny studie er godt nytt for gravide. [Internett]. Forskning.no.
• Lupattelli, Angela & Helleve, Torstein (2021). Antidepressiva i svangerskapet kan kanskje auke risikoen for ADHD hos barnet. [Internett]. Forskning.no.
• Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2021). Does antidepressant use in pregnancy increase the risk of ADHD in children? BestPractice nordic.
• Lupattelli, Angela; Karlstad, Øystein; Engeland, Anders; Småbrekke, Lars; Olsen, Kristine & Øvrebust, Aina [Vis alle 7 forfattere av denne artikkelen] (2021). The Norwegian Society for Pharmacoepidemiology. Norsk Epidemiologi. ISSN 0803-2491. 29(1-2), s. 5–6. doi: 10.5324/nje.v29i1-2.4039. Fulltekst i vitenarkiv
• Lupattelli, Angela; Spigset, Olav & Nordeng, Hedvig Marie Egeland (2020). Correction to: Learning the effects of psychotropic drugs during pregnancy using real‑world safety data: a paradigm shift toward modern pharmacovigilance (International Journal of Clinical Pharmacy, (2018), 40, 4, (783-786), 10.1007/s11096-018-0672-2). International Journal of Clinical Pharmacy. ISSN 2210-7703. doi: 10.1007/s11096-020-01104-2.
• Lupattelli, Angela (2019). Beroligende funn etter angst- og sovemedisinbruk hos gravide. [Internett]. https://titan.uio.no/node/3244?fbclid=IwAR0c6c4OlxHQFTawHdzv.
• Lupattelli, Angela (2019). How to attract funding.
• Lupattelli, Angela (2019). Safety of prenatal exposure to psychotropic medications: insights from neurodevelopmental research in children.
• Lupattelli, Angela (2019). Risk of Diagnosis and Symptoms of Attention Deficit Hyperactivity Disorder in Children After Prenatal Exposure to Serotoninergic Antidepressants .
• Lupattelli, Angela (2019). Maternal Use of Serotonergic Antidepressants during Pregnancy and Risk of ADHD Diagnosis and Symptoms in offspring .
• Lupattelli, Angela; Mahic, Milada; Handal, Marte; Ystrøm, Eivind; Reichborn-Kjennerud, Ted & Nordeng, Hedvig Marie Egeland (2019). Risk of attention deficit hyperactivity disorder in childhood after exposure to serotonergic antidepressants in pregnancy. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569.
• Handal, Marte; Skurtveit, Svetlana; Odsbu, Ingvild; Kieler, Helle; Nørgaard, Mette & Öztürk, Buket [Vis alle 12 forfattere av denne artikkelen] (2019). In utero opioid exposure and risk of ADHD in childhood: A Scandinavian registry study. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. 28(S2). doi: 10.1002/pds.4864.
• Lupattelli, Angela; Chambers, Christina; Bandoli, Gretchen; Handal, Marte; Skurtveit, Svetlana & Nordeng, Hedvig Marie Egeland (2018). Maternal use of benzodiazepines and z‐hypnotics during pregnancy and developmental outcomes in offspring at 5 years of age. Pharmacoepidemiology and Drug Safety. ISSN 1053-8569. 27(S2), s. 173–173. doi: 10.1002/pds.4629.
• Lupattelli, Angela & Nordeng, Hedvig Marie Egeland (2018). Dr. Lupattelli et al. Reply. Journal of the American Academy of Child and Adolescent Psychiatry. ISSN 0890-8567. 57(9), s. 699–700. doi: 10.1016/j.jaac.2018.06.011.
• Trønnes, Johanne Naper; Wood, Mollie; Lupattelli, Angela; Ystrom, Eivind & Nordeng, Hedvig Marie Egeland (2018). Association of prenatal paracetamol exposure with neurodevelopmental outcomes in 5-year-old children and the role of unmeasured confounding .
• Trønnes, Johanne Naper; Wood, Mollie; Lupattelli, Angela; Ystrom, Eivind & Nordeng, Hedvig Marie Egeland (2018). Association of prenatal paracetamol exposure with neurodevelopmental outcomes in 5-year-old children.
• Frank, Anna-Simone Josefine; Lupattelli, Angela; Matteson, David S. & Nordeng, Hedvig Marie Egeland (2018). Maternal Use of Thyroid Hormone Replacement Therapy: Group-Based Trajectory Modeling of Adherence and Agreement Between Self-Reporting and Prescription Records During Pregnancy.

Se alle arbeider i Cristin